ADAXION Therapeutics

Solving the Immunogenicity Challenge: Unlocking the Full Potential of Biologic Therapies

ADAXION is developing innovative treatments for immune-mediated and inflammatory diseases using its proprietary ADAx platform. This technology is designed to deimmunize protein therapeutics—preventing the formation of anti-drug antibodies (ADAs) that can compromise efficacy and trigger harmful immune responses.